GNRH1 and Kennedy disease: Thus far, trials have demonstrated mixed results with no statistically significant difference in progression of SBMA following exposure to a 5-alpha reductase inhibitor, while other studies demonstrated delayed progression after exposure to gonadotropin releasing hormone (GnRH) agonist in men with SBMA in comparison to controls [25–27].